口蹄疫疫苗市場：依疫苗類型、依動物類型、依地區

預計2024年全球口蹄疫疫苗市場規模為29億美元，預計2031年將達51.2億美元，2024年至2031年複合年成長率為8.5%。

圖 1. 2024 年按地區分類的口蹄疫疫苗市場佔有率(%)

口蹄疫 (FMD) 是一種高度傳染性的病毒性疾病，影響牛、豬、綿羊、山羊和鹿等有蹄牲畜。這種疾病可造成嚴重損害，包括直接影響產乳量和受感染牲畜的生長，以及透過預防、治療和貿易限制造成間接經濟損失。口蹄疫在亞洲、非洲和南美洲部分地區流行，目前正在實施緊急疫苗接種以遏制疫情爆發。隨著國際貿易和牲畜流動的增加，管理口蹄疫變得越來越困難，需要改善疫苗策略和干涉措施。

市場動態：

全球口蹄疫疫苗市場的成長是由以下因素推動的：牲畜口蹄疫盛行率不斷上升、氣候和耕作方式變化導致的全球疫情日益嚴重以及動物和牲畜的國際貿易產品。然而，與疫苗生產、儲存和設備再利用相關的高成本可能會阻礙市場成長。此外，各國疫苗核准缺乏標準化監管指引也阻礙了市場成長。新興的分子生物學技術能夠開發具有改善的免疫抗原性和交叉保護的新一代疫苗，可能會提供市場成長的機會。在以前缺乏口蹄疫控制的國家中，對口蹄疫控制的日益重視可能會開拓新的應用領域。

本研究的主要特點

• 本報告對全球口蹄疫疫苗市場進行了詳細分析，並列出了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為預測期。做。
• 它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球口蹄疫疫苗市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• 全球口蹄疫疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過用於分析全球口蹄疫疫苗市場的各種策略矩陣來促進決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管場景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

第4章全球口蹄疫疫苗市場－冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第5章2019-2031年全球口蹄疫疫苗市場（依疫苗類型）

• 常規疫苗
• 氫氧化鋁疫苗
• 油性疫苗
• 緊急疫苗

第6章 全球口蹄疫疫苗市場（依動物類型），2019-2031

• 牛
• 綿羊和山羊
• 豬
• 其他

第7章2019-2031年全球口蹄疫疫苗市場（按地區）

• 拉丁美洲
• 歐洲
• 亞太地區
• 中東

第8章 競爭格局

• 公司簡介
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck &Co., Inc.（MSD Animal Health）
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica SA
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI-Federal Centre for Animal Health
  • Vecol SA
  • Laboratorios Agrovet SA
  • Centro Diagnostico Veterinario
  • Razi Vaccine &Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

第9章 分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第10章 參考文獻與調查方法

• 參考
• 調查方法

Global foot and mouth disease vaccine market is estimated to be valued at USD 2.90 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5 % from 2024 to 2031.

Figure 1. Foot and Mouth Disease Vaccine Market Share (%), By Region, 2024

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals including cattle, pigs, sheep, goats, deer and other livestock. The disease can cause severe damage both direct loss in milk yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control outbreaks. With growing international trade and movement of livestock, controlling FMD has become more challenging, thus, requiring improved vaccination strategies and interventions.

Market Dynamics:

Global foot and mouth disease vaccine market growth is driven by factors such as increasing prevalence of FMD amongst livestock, growing outbreaks worldwide due to changes in climate and farming practices as well as international trade in animals and animal products. However, high costs associated with vaccine production and storage and reuse of equipment can hamper the market growth. Furthermore, lack of standardized regulatory guidelines for vaccine approval in different countries also hampers the market growth. Advancements in molecular biological techniques that enables development of new generation vaccines with improved immunogenicity and cross-protection can offer market growth opportunity. Growing focus on controlling FMD in previously FMD-free countries can open new application areas.

Key Features of the Study:

• This report provides in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Biogenesis Bago, Indian Immunologicals Ltd., Boehringer Ingelheim, Vetal Animal Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation

• By Vaccine Type:
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• By Animal Type
  • Cattle
  • Sheep and Goat
  • Swine
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Foot and Mouth Disease Vaccine Market, By Vaccine Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Conventional Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Aluminum Hydroxide based vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Oil based Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Emergency Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Foot and Mouth Disease Vaccine Market, By Animal Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cattle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Sheep and Goat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Swine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Foot and Mouth Disease Vaccine Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc. (MSD Animal Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Limber Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Brilliant Bio Pharma Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact